UA75624C2 - Method for preparing aqueous extracts of plants, extracts obtained (variants), raw material for preparing extracts - Google Patents
Method for preparing aqueous extracts of plants, extracts obtained (variants), raw material for preparing extracts Download PDFInfo
- Publication number
- UA75624C2 UA75624C2 UA2003065992A UA2003065992A UA75624C2 UA 75624 C2 UA75624 C2 UA 75624C2 UA 2003065992 A UA2003065992 A UA 2003065992A UA 2003065992 A UA2003065992 A UA 2003065992A UA 75624 C2 UA75624 C2 UA 75624C2
- Authority
- UA
- Ukraine
- Prior art keywords
- treatment
- cancer
- plant
- water
- fact
- Prior art date
Links
- 238000000034 method Methods 0.000 title claims abstract description 63
- 239000006286 aqueous extract Substances 0.000 title claims abstract description 34
- 239000000284 extract Substances 0.000 title claims description 40
- 239000002994 raw material Substances 0.000 title claims description 14
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 claims abstract description 54
- 238000011282 treatment Methods 0.000 claims abstract description 35
- 239000000203 mixture Substances 0.000 claims abstract description 25
- 201000010099 disease Diseases 0.000 claims abstract description 18
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 claims abstract description 18
- 230000005855 radiation Effects 0.000 claims abstract description 15
- 239000000725 suspension Substances 0.000 claims abstract description 15
- 238000000926 separation method Methods 0.000 claims abstract description 13
- 239000003814 drug Substances 0.000 claims abstract description 11
- 230000003612 virological effect Effects 0.000 claims abstract description 10
- 239000007788 liquid Substances 0.000 claims abstract description 8
- 238000002803 maceration Methods 0.000 claims abstract description 8
- 239000000126 substance Substances 0.000 claims description 19
- BPYKTIZUTYGOLE-IFADSCNNSA-N Bilirubin Chemical compound N1C(=O)C(C)=C(C=C)\C1=C\C1=C(C)C(CCC(O)=O)=C(CC2=C(C(C)=C(\C=C/3C(=C(C=C)C(=O)N\3)C)N2)CCC(O)=O)N1 BPYKTIZUTYGOLE-IFADSCNNSA-N 0.000 claims description 14
- 238000005406 washing Methods 0.000 claims description 12
- 150000001875 compounds Chemical class 0.000 claims description 10
- 238000001914 filtration Methods 0.000 claims description 10
- 238000000227 grinding Methods 0.000 claims description 8
- 206010028980 Neoplasm Diseases 0.000 claims description 7
- 108090000340 Transaminases Proteins 0.000 claims description 7
- 102000003929 Transaminases Human genes 0.000 claims description 7
- 201000011510 cancer Diseases 0.000 claims description 7
- 239000007790 solid phase Substances 0.000 claims description 7
- 230000001506 immunosuppresive effect Effects 0.000 claims description 6
- 239000007791 liquid phase Substances 0.000 claims description 6
- 239000011148 porous material Substances 0.000 claims description 6
- 208000030507 AIDS Diseases 0.000 claims description 5
- 206010020751 Hypersensitivity Diseases 0.000 claims description 5
- 201000004681 Psoriasis Diseases 0.000 claims description 5
- 230000007815 allergy Effects 0.000 claims description 5
- 208000005252 hepatitis A Diseases 0.000 claims description 5
- 206010022000 influenza Diseases 0.000 claims description 5
- 206010025135 lupus erythematosus Diseases 0.000 claims description 5
- 229940124597 therapeutic agent Drugs 0.000 claims description 5
- 201000008827 tuberculosis Diseases 0.000 claims description 5
- 238000004140 cleaning Methods 0.000 claims description 4
- 238000010908 decantation Methods 0.000 claims description 4
- 239000000825 pharmaceutical preparation Substances 0.000 claims description 4
- 206010003571 Astrocytoma Diseases 0.000 claims description 3
- 206010005003 Bladder cancer Diseases 0.000 claims description 3
- 208000003174 Brain Neoplasms Diseases 0.000 claims description 3
- 206010006187 Breast cancer Diseases 0.000 claims description 3
- 208000026310 Breast neoplasm Diseases 0.000 claims description 3
- 206010008342 Cervix carcinoma Diseases 0.000 claims description 3
- 206010009944 Colon cancer Diseases 0.000 claims description 3
- 208000008839 Kidney Neoplasms Diseases 0.000 claims description 3
- 206010058467 Lung neoplasm malignant Diseases 0.000 claims description 3
- 206010060862 Prostate cancer Diseases 0.000 claims description 3
- 208000000236 Prostatic Neoplasms Diseases 0.000 claims description 3
- 206010038389 Renal cancer Diseases 0.000 claims description 3
- 208000007097 Urinary Bladder Neoplasms Diseases 0.000 claims description 3
- 208000006105 Uterine Cervical Neoplasms Diseases 0.000 claims description 3
- 201000010881 cervical cancer Diseases 0.000 claims description 3
- 208000019425 cirrhosis of liver Diseases 0.000 claims description 3
- 208000029742 colonic neoplasm Diseases 0.000 claims description 3
- 208000005017 glioblastoma Diseases 0.000 claims description 3
- 210000003494 hepatocyte Anatomy 0.000 claims description 3
- 239000012535 impurity Substances 0.000 claims description 3
- 201000010982 kidney cancer Diseases 0.000 claims description 3
- 201000007270 liver cancer Diseases 0.000 claims description 3
- 208000014018 liver neoplasm Diseases 0.000 claims description 3
- 201000005202 lung cancer Diseases 0.000 claims description 3
- 208000020816 lung neoplasm Diseases 0.000 claims description 3
- 230000007170 pathology Effects 0.000 claims description 3
- 201000005825 prostate adenocarcinoma Diseases 0.000 claims description 3
- 230000008929 regeneration Effects 0.000 claims description 3
- 238000011069 regeneration method Methods 0.000 claims description 3
- 201000005112 urinary bladder cancer Diseases 0.000 claims description 3
- 230000004936 stimulating effect Effects 0.000 claims description 2
- 238000004519 manufacturing process Methods 0.000 claims 7
- 229940126601 medicinal product Drugs 0.000 claims 7
- 208000010667 Carcinoma of liver and intrahepatic biliary tract Diseases 0.000 claims 2
- 206010073069 Hepatic cancer Diseases 0.000 claims 2
- 206010073071 hepatocellular carcinoma Diseases 0.000 claims 2
- 201000002250 liver carcinoma Diseases 0.000 claims 2
- 201000009240 nasopharyngitis Diseases 0.000 claims 2
- 239000003937 drug carrier Substances 0.000 claims 1
- 238000012876 topography Methods 0.000 claims 1
- 238000005202 decontamination Methods 0.000 abstract 1
- 230000003588 decontaminative effect Effects 0.000 abstract 1
- 239000003018 immunosuppressive agent Substances 0.000 abstract 1
- 241000196324 Embryophyta Species 0.000 description 53
- 230000000694 effects Effects 0.000 description 17
- 210000004698 lymphocyte Anatomy 0.000 description 8
- 230000008569 process Effects 0.000 description 6
- 239000007787 solid Substances 0.000 description 5
- 241000894007 species Species 0.000 description 5
- 239000013543 active substance Substances 0.000 description 4
- 239000002552 dosage form Substances 0.000 description 4
- 238000013532 laser treatment Methods 0.000 description 4
- 239000000463 material Substances 0.000 description 4
- 238000002360 preparation method Methods 0.000 description 4
- 238000012545 processing Methods 0.000 description 4
- 210000004185 liver Anatomy 0.000 description 3
- 239000008194 pharmaceutical composition Substances 0.000 description 3
- 208000036071 Rhinorrhea Diseases 0.000 description 2
- 206010039101 Rhinorrhoea Diseases 0.000 description 2
- IQFYYKKMVGJFEH-XLPZGREQSA-N Thymidine Chemical compound O=C1NC(=O)C(C)=CN1[C@@H]1O[C@H](CO)[C@@H](O)C1 IQFYYKKMVGJFEH-XLPZGREQSA-N 0.000 description 2
- 241000700605 Viruses Species 0.000 description 2
- 239000011230 binding agent Substances 0.000 description 2
- 239000000969 carrier Substances 0.000 description 2
- 238000005119 centrifugation Methods 0.000 description 2
- 238000011109 contamination Methods 0.000 description 2
- 238000001035 drying Methods 0.000 description 2
- 208000006454 hepatitis Diseases 0.000 description 2
- 231100000283 hepatitis Toxicity 0.000 description 2
- 239000003960 organic solvent Substances 0.000 description 2
- 102100036475 Alanine aminotransferase 1 Human genes 0.000 description 1
- 108010082126 Alanine transaminase Proteins 0.000 description 1
- DWRXFEITVBNRMK-UHFFFAOYSA-N Beta-D-1-Arabinofuranosylthymine Natural products O=C1NC(=O)C(C)=CN1C1C(O)C(O)C(CO)O1 DWRXFEITVBNRMK-UHFFFAOYSA-N 0.000 description 1
- 201000009030 Carcinoma Diseases 0.000 description 1
- 230000004543 DNA replication Effects 0.000 description 1
- 206010016654 Fibrosis Diseases 0.000 description 1
- 108020004206 Gamma-glutamyltransferase Proteins 0.000 description 1
- 208000005176 Hepatitis C Diseases 0.000 description 1
- 241000699670 Mus sp. Species 0.000 description 1
- 241000592342 Tracheophyta Species 0.000 description 1
- 230000002411 adverse Effects 0.000 description 1
- 150000001298 alcohols Chemical class 0.000 description 1
- 230000000840 anti-viral effect Effects 0.000 description 1
- 210000003719 b-lymphocyte Anatomy 0.000 description 1
- 230000008901 benefit Effects 0.000 description 1
- IQFYYKKMVGJFEH-UHFFFAOYSA-N beta-L-thymidine Natural products O=C1NC(=O)C(C)=CN1C1OC(CO)C(O)C1 IQFYYKKMVGJFEH-UHFFFAOYSA-N 0.000 description 1
- 238000006243 chemical reaction Methods 0.000 description 1
- 230000007882 cirrhosis Effects 0.000 description 1
- 229940079593 drug Drugs 0.000 description 1
- 238000002474 experimental method Methods 0.000 description 1
- 238000000605 extraction Methods 0.000 description 1
- 102000006640 gamma-Glutamyltransferase Human genes 0.000 description 1
- 239000008131 herbal destillate Substances 0.000 description 1
- 210000000987 immune system Anatomy 0.000 description 1
- 230000007233 immunological mechanism Effects 0.000 description 1
- 229910052500 inorganic mineral Inorganic materials 0.000 description 1
- 238000007918 intramuscular administration Methods 0.000 description 1
- 238000001990 intravenous administration Methods 0.000 description 1
- 208000019423 liver disease Diseases 0.000 description 1
- 210000002540 macrophage Anatomy 0.000 description 1
- 230000004060 metabolic process Effects 0.000 description 1
- 239000011707 mineral Substances 0.000 description 1
- 238000012986 modification Methods 0.000 description 1
- 230000004048 modification Effects 0.000 description 1
- 239000000419 plant extract Substances 0.000 description 1
- 238000011084 recovery Methods 0.000 description 1
- 230000009467 reduction Effects 0.000 description 1
- 230000001105 regulatory effect Effects 0.000 description 1
- 238000011160 research Methods 0.000 description 1
- 206010039083 rhinitis Diseases 0.000 description 1
- 239000002002 slurry Substances 0.000 description 1
- 238000010561 standard procedure Methods 0.000 description 1
- 238000007920 subcutaneous administration Methods 0.000 description 1
- 238000012360 testing method Methods 0.000 description 1
- 230000001225 therapeutic effect Effects 0.000 description 1
- 229940104230 thymidine Drugs 0.000 description 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/30—Boraginaceae (Borage family), e.g. comfrey, lungwort or forget-me-not
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/28—Asteraceae or Compositae (Aster or Sunflower family), e.g. chamomile, feverfew, yarrow or echinacea
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/11—Pteridophyta or Filicophyta (ferns)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/23—Apiaceae or Umbelliferae (Carrot family), e.g. dill, chervil, coriander or cumin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/25—Araliaceae (Ginseng family), e.g. ivy, aralia, schefflera or tetrapanax
- A61K36/254—Acanthopanax or Eleutherococcus
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/31—Brassicaceae or Cruciferae (Mustard family), e.g. broccoli, cabbage or kohlrabi
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/53—Lamiaceae or Labiatae (Mint family), e.g. thyme, rosemary or lavender
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/53—Lamiaceae or Labiatae (Mint family), e.g. thyme, rosemary or lavender
- A61K36/534—Mentha (mint)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/73—Rosaceae (Rose family), e.g. strawberry, chokeberry, blackberry, pear or firethorn
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
- A61K9/19—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles lyophilised, i.e. freeze-dried, solutions or dispersions
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/16—Drugs for disorders of the alimentary tract or the digestive system for liver or gallbladder disorders, e.g. hepatoprotective agents, cholagogues, litholytics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
- A61P17/02—Drugs for dermatological disorders for treating wounds, ulcers, burns, scars, keloids, or the like
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
- A61P17/06—Antipsoriatics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/04—Antibacterial agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/04—Antibacterial agents
- A61P31/06—Antibacterial agents for tuberculosis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
- A61P31/14—Antivirals for RNA viruses
- A61P31/16—Antivirals for RNA viruses for influenza or rhinoviruses
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
- A61P31/14—Antivirals for RNA viruses
- A61P31/18—Antivirals for RNA viruses for HIV
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
- A61P31/20—Antivirals for DNA viruses
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/02—Immunomodulators
- A61P37/04—Immunostimulants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/02—Immunomodulators
- A61P37/06—Immunosuppressants, e.g. drugs for graft rejection
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/08—Antiallergic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K2800/00—Properties of cosmetic compositions or active ingredients thereof or formulation aids used therein and process related aspects
- A61K2800/80—Process related aspects concerning the preparation of the cosmetic composition or the storage or application thereof
- A61K2800/84—Products or compounds obtained by lyophilisation, freeze-drying
-
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
- Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
- Y02A50/00—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
- Y02A50/30—Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change
Landscapes
- Health & Medical Sciences (AREA)
- Natural Medicines & Medicinal Plants (AREA)
- Life Sciences & Earth Sciences (AREA)
- Medicinal Chemistry (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Chemical & Material Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Engineering & Computer Science (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Biotechnology (AREA)
- Organic Chemistry (AREA)
- General Chemical & Material Sciences (AREA)
- Epidemiology (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Microbiology (AREA)
- Mycology (AREA)
- Alternative & Traditional Medicine (AREA)
- Botany (AREA)
- Medical Informatics (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Immunology (AREA)
- Virology (AREA)
- Communicable Diseases (AREA)
- Oncology (AREA)
- Pulmonology (AREA)
- Molecular Biology (AREA)
- Dermatology (AREA)
- Transplantation (AREA)
- Gastroenterology & Hepatology (AREA)
- AIDS & HIV (AREA)
- Tropical Medicine & Parasitology (AREA)
- Medicines Containing Plant Substances (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Coloring Foods And Improving Nutritive Qualities (AREA)
- Agricultural Chemicals And Associated Chemicals (AREA)
- Extraction Or Liquid Replacement (AREA)
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| PCT/IB2000/001947 WO2002041908A1 (en) | 2000-11-27 | 2000-11-27 | Process for preparing aqueous extracts of plants and extracts so obtained |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| UA75624C2 true UA75624C2 (en) | 2006-05-15 |
Family
ID=11004018
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| UA2003065992A UA75624C2 (en) | 2000-11-27 | 2000-11-27 | Method for preparing aqueous extracts of plants, extracts obtained (variants), raw material for preparing extracts |
Country Status (23)
| Country | Link |
|---|---|
| US (1) | US7402324B1 (hu) |
| EP (1) | EP1339420B1 (hu) |
| JP (1) | JP2004525866A (hu) |
| KR (1) | KR100775153B1 (hu) |
| CN (1) | CN1261162C (hu) |
| AR (1) | AR035506A1 (hu) |
| AT (1) | ATE275960T1 (hu) |
| AU (2) | AU2019501A (hu) |
| BR (1) | BR0017378A (hu) |
| CA (1) | CA2430113A1 (hu) |
| DE (1) | DE60013919T2 (hu) |
| DK (1) | DK1339420T3 (hu) |
| ES (1) | ES2228641T3 (hu) |
| HR (1) | HRP20030482A2 (hu) |
| HU (1) | HUP0501092A3 (hu) |
| IL (1) | IL156165A0 (hu) |
| MX (1) | MXPA03004721A (hu) |
| MY (1) | MY129109A (hu) |
| NO (1) | NO20032369L (hu) |
| NZ (1) | NZ526642A (hu) |
| PT (1) | PT1339420E (hu) |
| UA (1) | UA75624C2 (hu) |
| WO (1) | WO2002041908A1 (hu) |
Families Citing this family (10)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO2004002945A1 (en) * | 2002-06-29 | 2004-01-08 | Biokorea Co., Ltd | (e)-1-[[(2e, 4e)-1-hexyl-2,4-octadecadienyl]oxy]-2-hydroxydiazine and a pharmaceutical composition for treating hepatitis |
| WO2007141661A2 (en) * | 2006-02-22 | 2007-12-13 | Tracey Anne Seipel | Herbal compositions for the prevention or treatment of benign prostatic hyperplasia |
| CA2677783A1 (en) * | 2007-02-13 | 2008-08-21 | Caleco Pharma Corp. | Compositions and methods for treatment of liver disease |
| KR101124364B1 (ko) * | 2009-03-31 | 2012-03-15 | (주)국심 | 간세포 보호 기능성 국화차 조성물 |
| US20120213870A1 (en) * | 2011-02-17 | 2012-08-23 | Maher El-Aaser | Composition and method for treating liver disease |
| US10758581B2 (en) | 2013-06-11 | 2020-09-01 | Carmel Haifa University Economic Corporation Ltd. | Treatment of cancer |
| ES2533200B1 (es) * | 2013-10-04 | 2016-01-15 | Rafael GALLART GRAU | Procedimiento para preparar extractos acuosos de plantas |
| FR3023482B1 (fr) * | 2014-07-11 | 2016-07-15 | Laboratoires Lea | Extrait hydroglycerine d'ombellifere pour un usage cosmetique |
| TR201514423A3 (tr) | 2015-11-16 | 2017-02-21 | Bahadir Sueleyman | Kanser tedavisi için bir ekstre. |
| CN112808243A (zh) * | 2021-01-07 | 2021-05-18 | 广州宝力环保科技有限公司 | 一种高效去除甲醛空气净化剂 |
Family Cites Families (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| FR2733419B1 (fr) | 1995-04-27 | 1997-08-08 | Blackborough Ltd | Extraits vegetaux, leur procede de fabrication, conjugues phytoproteiques les contenant et leurs applications |
| RU2118166C1 (ru) | 1996-12-04 | 1998-08-27 | Государственный научный центр РФ "НИОПИК" | Средство для лечения онкологических заболеваний в виде водного экстракта растительного сырья и способ его получения |
| US6143337A (en) * | 1999-04-30 | 2000-11-07 | The United States Of America As Represented By The Secretary Of Agriculture | Extraction of pectin by microwave heating under pressure |
-
2000
- 2000-11-27 US US10/432,696 patent/US7402324B1/en not_active Expired - Fee Related
- 2000-11-27 DK DK00983441T patent/DK1339420T3/da active
- 2000-11-27 AU AU2019501A patent/AU2019501A/xx active Pending
- 2000-11-27 CA CA002430113A patent/CA2430113A1/en not_active Abandoned
- 2000-11-27 KR KR1020037007001A patent/KR100775153B1/ko not_active IP Right Cessation
- 2000-11-27 UA UA2003065992A patent/UA75624C2/uk unknown
- 2000-11-27 DE DE60013919T patent/DE60013919T2/de not_active Expired - Fee Related
- 2000-11-27 EP EP00983441A patent/EP1339420B1/en not_active Expired - Lifetime
- 2000-11-27 JP JP2002544086A patent/JP2004525866A/ja not_active Abandoned
- 2000-11-27 IL IL15616500A patent/IL156165A0/xx not_active IP Right Cessation
- 2000-11-27 HU HU0501092A patent/HUP0501092A3/hu unknown
- 2000-11-27 PT PT00983441T patent/PT1339420E/pt unknown
- 2000-11-27 NZ NZ526642A patent/NZ526642A/en unknown
- 2000-11-27 AT AT00983441T patent/ATE275960T1/de not_active IP Right Cessation
- 2000-11-27 WO PCT/IB2000/001947 patent/WO2002041908A1/en active IP Right Grant
- 2000-11-27 AU AU2001220195A patent/AU2001220195B2/en not_active Ceased
- 2000-11-27 CN CNB008200955A patent/CN1261162C/zh not_active Expired - Fee Related
- 2000-11-27 ES ES00983441T patent/ES2228641T3/es not_active Expired - Lifetime
- 2000-11-27 BR BR0017378-9A patent/BR0017378A/pt not_active Application Discontinuation
- 2000-11-27 MX MXPA03004721A patent/MXPA03004721A/es active IP Right Grant
-
2001
- 2001-11-26 MY MYPI20015383A patent/MY129109A/en unknown
- 2001-11-26 AR ARP010105480A patent/AR035506A1/es not_active Application Discontinuation
-
2003
- 2003-05-26 NO NO20032369A patent/NO20032369L/no not_active Application Discontinuation
- 2003-06-13 HR HR20030482A patent/HRP20030482A2/hr not_active Application Discontinuation
Also Published As
| Publication number | Publication date |
|---|---|
| EP1339420B1 (en) | 2004-09-15 |
| KR20030063393A (ko) | 2003-07-28 |
| NO20032369D0 (no) | 2003-05-26 |
| IL156165A0 (en) | 2003-12-23 |
| AU2019501A (en) | 2002-06-03 |
| CA2430113A1 (en) | 2002-05-30 |
| PT1339420E (pt) | 2005-01-31 |
| US7402324B1 (en) | 2008-07-22 |
| BR0017378A (pt) | 2004-06-29 |
| HUP0501092A2 (en) | 2007-12-28 |
| MXPA03004721A (es) | 2005-01-25 |
| DE60013919D1 (de) | 2004-10-21 |
| DK1339420T3 (da) | 2005-01-17 |
| KR100775153B1 (ko) | 2007-11-12 |
| MY129109A (en) | 2007-03-30 |
| EP1339420A1 (en) | 2003-09-03 |
| NO20032369L (no) | 2003-07-25 |
| WO2002041908A1 (en) | 2002-05-30 |
| DE60013919T2 (de) | 2005-09-29 |
| HRP20030482A2 (en) | 2005-04-30 |
| AR035506A1 (es) | 2004-06-02 |
| NZ526642A (en) | 2004-11-26 |
| ATE275960T1 (de) | 2004-10-15 |
| AU2001220195B2 (en) | 2005-10-27 |
| ES2228641T3 (es) | 2005-04-16 |
| JP2004525866A (ja) | 2004-08-26 |
| HUP0501092A3 (en) | 2008-08-28 |
| CN1261162C (zh) | 2006-06-28 |
| CN1479624A (zh) | 2004-03-03 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| US5908857A (en) | Agent for the treatment of infections | |
| UA75624C2 (en) | Method for preparing aqueous extracts of plants, extracts obtained (variants), raw material for preparing extracts | |
| KR100523562B1 (ko) | 손바닥선인장 추출물 및 이로부터 분리된 화합물을함유하는 신경세포 보호용 조성물 | |
| KR100382564B1 (ko) | 치매병 예방 및 치료용 생약조성물 | |
| JPH03505325A (ja) | レトロウイルス感染治療法 | |
| AU2001220195A1 (en) | Process for preparing aqueous extracts of plants and extracts so obtained | |
| JPH0725777A (ja) | 神経栄養因子合成促進剤 | |
| WO1986005180A1 (en) | Novel tannin composition | |
| EP1450833A2 (en) | Anti-hsv agent for inhibiting replication of hsv-1 and hsv-2 and method of producing a substance having anti-hsv activity | |
| JPH04266828A (ja) | 植物抽出物及びその用途 | |
| RU2265448C2 (ru) | Способ получения водных экстрактов из растений и сами эти экстракты | |
| JP2003500346A (ja) | 皮膚美白剤 | |
| KR100502835B1 (ko) | 영지추출물, 올레아미드 및 그의 구조적 유사체를유효성분으로 함유하는 치매의 예방 및 치료용 조성물 | |
| EP0793964A1 (en) | Compositions for treatment of Hepatitis C | |
| JP3010258B2 (ja) | 抗ｈｉｖ剤 | |
| CN110536690B (zh) | 用于预防或治疗丙型肝炎病毒感染疾病的药学组合物 | |
| JPH07126180A (ja) | 発癌抑制剤 | |
| WO2001082941A1 (en) | Composition for treatment of b-type hepatitis and liver cirrhosis | |
| TWI299267B (en) | Process for preparing aqueous extracts of plants, extracts so obtained,their uses and pharmaceutical preparations containing the extracts | |
| JPH07258104A (ja) | 癌転移抑制剤 | |
| JP3226321B2 (ja) | 新規な発毛・育毛促進剤 | |
| KR100332485B1 (ko) | 마황 추출물을 유효성분으로 하는 ｂ형 간염 치료제 | |
| SA02220687B1 (ar) | طريقة لتحضير مستخلصات مائية من نباتات والمستخلصات التي يتم الحصول عليها بتك الطريقة | |
| JP2004323510A (ja) | 鎮咳剤およびその調製方法 | |
| JPS5936623A (ja) | インタ−フエロン誘起剤 |